What is the main goal of HHS's new 'Operation TrialBlazer' initiative?

The main goal of HHS's 'Operation TrialBlazer' initiative is to speed up regulatory checkpoints in the clinical trials of new drugs in the US, addressing industry criticism that it is difficult to obtain regulatory approval to test new drug candidates domestically.

Why does HHS consider it problematic that drug developers are moving clinical trials overseas?

HHS considers it problematic because the shift of clinical trials overseas—especially to countries like China and Australia—threatens American medical innovation, as stated by HHS Secretary Robert F. Kennedy Jr. in a commentary accompanying the initiative.

Policy Watch: HHS Moves to Keep More Drug Trials in the US

Jun 26, 2026

The US Department of Health and Human Services announced Operation TrialBlazer to accelerate regulatory checkpoints for new drug clinical trials. HHS Secretary Robert F. Kennedy Jr. aims to reverse the trend of developers moving trials abroad to protect American medical innovation.

cen

2026-06-26

Policy Watch: HHS Moves to Keep More Drug Trials in the US

Policy Watch: HHS Moves to Keep More Drug Trials in the US

FAQ